Chang JC - Search Results

1

Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer.

Rimawi MF, De Angelis C, Contreras A, Pareja F, Geyer FC, Burke KA, Herrera S, Wang T, Mayer IA, Forero A, Nanda R, Goetz MP, Chang JC, Krop IE, Wolff AC, Pavlick AC, Fuqua SAW, Gutierrez C, Hilsenbeck SG, Li MM, Weigelt B, Reis-Filho JS, Kent Osborne C, Schiff R. Rimawi MF, et al. Among authors: chang jc. Breast Cancer Res Treat. 2018 Feb;167(3):731-740. doi: 10.1007/s10549-017-4533-9. Epub 2017 Nov 7. Breast Cancer Res Treat. 2018. PMID: 29110152 Free PMC article. Clinical Trial.

2

Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients.

Chang J, Hilsenbeck SG, Sng JH, Wong J, Ragu GC. Chang J, et al. Clin Cancer Res. 2001 Jun;7(6):1739-42. Clin Cancer Res. 2001. PMID: 11410514

3

Clinical management of women with genomic BRCA1 and BRCA2 mutations.

Chang J, Elledge RM. Chang J, et al. Breast Cancer Res Treat. 2001 Sep;69(2):101-13. doi: 10.1023/a:1012203917104. Breast Cancer Res Treat. 2001. PMID: 11759816 Review.

4

Reversible and irreversible cardiac dysfunction associated with trastuzumab in breast cancer.

Tham YL, Verani MS, Chang J. Tham YL, et al. Breast Cancer Res Treat. 2002 Jul;74(2):131-4. doi: 10.1023/a:1016140729725. Breast Cancer Res Treat. 2002. PMID: 12186373

5

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer.

Chang JC, Wooten EC, Tsimelzon A, Hilsenbeck SG, Gutierrez MC, Elledge R, Mohsin S, Osborne CK, Chamness GC, Allred DC, O'Connell P. Chang JC, et al. Lancet. 2003 Aug 2;362(9381):362-9. doi: 10.1016/S0140-6736(03)14023-8. Lancet. 2003. PMID: 12907009

6

Neoadjuvant trastuzumab and docetaxel in breast cancer: preliminary results.

Van Pelt AE, Mohsin S, Elledge RM, Hilsenbeck SG, Gutierrez MC, Lucci A Jr, Kalidas M, Granchi T, Scott BG, Allred DC, Chang JC. Van Pelt AE, et al. Among authors: chang jc. Clin Breast Cancer. 2003 Dec;4(5):348-53. doi: 10.3816/cbc.2003.n.040. Clin Breast Cancer. 2003. PMID: 14715110

7

Genomic approaches to understanding and treating breast cancer.

Fuqua SA, Chang JC, Hilsenbeck SG. Fuqua SA, et al. Among authors: chang jc. Breast Dis. 2004;19:35-46. doi: 10.3233/bd-2004-19106. Breast Dis. 2004. PMID: 15687696

8

Neoadjuvant trastuzumab induces apoptosis in primary breast cancers.

Mohsin SK, Weiss HL, Gutierrez MC, Chamness GC, Schiff R, Digiovanna MP, Wang CX, Hilsenbeck SG, Osborne CK, Allred DC, Elledge R, Chang JC. Mohsin SK, et al. Among authors: chang jc. J Clin Oncol. 2005 Apr 10;23(11):2460-8. doi: 10.1200/JCO.2005.00.661. Epub 2005 Feb 14. J Clin Oncol. 2005. PMID: 15710948 Clinical Trial.

9

Genomic approaches in the management and treatment of breast cancer.

Chang JC, Hilsenbeck SG, Fuqua SA. Chang JC, et al. Br J Cancer. 2005 Feb 28;92(4):618-24. doi: 10.1038/sj.bjc.6602410. Br J Cancer. 2005. PMID: 15714204 Free PMC article. Review.

10

Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients.

Chang JC, Wooten EC, Tsimelzon A, Hilsenbeck SG, Gutierrez MC, Tham YL, Kalidas M, Elledge R, Mohsin S, Osborne CK, Chamness GC, Allred DC, Lewis MT, Wong H, O'Connell P. Chang JC, et al. J Clin Oncol. 2005 Feb 20;23(6):1169-77. doi: 10.1200/JCO.2005.03.156. J Clin Oncol. 2005. PMID: 15718313

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,254 results

Search Page